Dietary Calanus oil recovers metabolic flexibility and rescues postischemic cardiac function in obese female mice.
Am J Physiol Heart Circ Physiol · 2019
Last updated 2026-05-28In a study on obese female mice, feeding them a diet with 2% Calanus oil or a drug called exenatide for 8 weeks reduced fat buildup compared to mice on a high-fat diet without supplements. Both Calanus oil and exenatide improved how the heart used glucose for energy, but only Calanus oil led to better recovery of heart function after a period of restricted blood flow, showing stronger pressure, contraction, and relaxation.
AI summary of the abstract below.
| Journal | Am J Physiol Heart Circ Physiol, 2019 |
|---|---|
| Citations | 14 |
| Relative citation ratio | 0.73 |
| NIH percentile | 40 |
| Molecules | — |
| Conditions studied | Obesity, Cardiovascular Risk Reduction |
Abstract
The aim of this study was to find out whether dietary supplementation with Calanus oil (a novel marine oil) or infusion of exenatide (an incretin mimetic) could counteract obesity-induced alterations in myocardial metabolism and improve postischemic recovery of left ventricular (LV) function. Female C57bl/6J mice received high-fat diet (HFD, 45% energy from fat) for 12 wk followed by 8-wk feeding with nonsupplemented HFD, HFD supplemented with 2% Calanus oil, or HFD plus exenatide infusion (10 µg·kg·day). A lean control group was included, receiving normal chow throughout the whole period. Fatty acid and glucose oxidation was measured in ex vivo perfused hearts during baseline conditions, while LV function was assessed with an intraventricular fluid-filled balloon before and after 20 min of global ischemia. HFD-fed mice receiving Calanus oil or exenatide showed less intra-abdominal fat deposition than mice receiving nonsupplemented HFD. Both treatments prevented the HFD-induced decline in myocardial glucose oxidation. Somewhat surprising, recovery of LV function was apparently better in hearts from mice fed nonsupplemented HFD relative to hearts from mice fed normal chow. More importantly however, postischemic recovery of hearts from mice receiving HFD with Calanus oil was superior to that of mice receiving nonsupplemented HFD and mice receiving HFD with exenatide, as expressed by better pressure development, contractility, and relaxation properties. In summary, dietary Calanus oil and administration of exenatide counteracted obesity-induced derangements of myocardial metabolism. Calanus oil also protected the heart from ischemia, which could have implications for the prevention of obesity-related cardiac disease. This article describes for the first time that dietary supplementation with a low amount (2%) of a novel marine oil (Calanus oil) in mice is able to prevent the overreliance of fatty acid oxidation for energy production during obesity. The same effect was observed with infusion of the incretin mimetic, exanatide. The improvement in myocardial metabolism in Calanus oil-treated mice was accompanied by a significantly better recovery of cardiac performance following ischemia-reperfusion. Listen to this article's corresponding podcast at https://ajpheart.podbean.com/e/dietary-calanus-oil-energy-metabolism-and-cardiac-function/ .
Verbatim abstract via PubMed 31125256 ↗